B3 Tree Pollens 2.5% solution for skin prick test

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Oak (Common, Quercus species) pollen allergen extract; Salix species pollen allergen extract; Poplar (Populus species) pollen allergen extract; Plane (Platanus species) pollen allergen extract; Hazel (Corylus species) pollen allergen extract; Ulmus species pollen allergen extract; Birch (Betula species) pollen allergen extract; Beech (Fagus species) pollen allergen extract; Ash (Fraxinus species) pollen allergen extract; Alder (Alnus species) pollen allergen extract

Available from:

Allergy Therapeutics (UK) Ltd

ATC code:

V04CL

INN (International Name):

Oak (Common, Quercus species) pollen allergen extract; Salix species pollen allergen extract; Poplar (Populus species) pollen allergen extract; Plane (Platanus species) pollen allergen extract; Hazel (Corylus species) pollen allergen extract; Ulmus species pollen allergen extract; Birch (Betula species) pollen allergen extract; Beech (Fagus species) pollen allergen extract; Ash (Fraxinus species) pollen allergen extract; Alder (Alnus species) pollen allergen extract

Pharmaceutical form:

Solution for skin-prick test

Administration route:

Intraepidermal

Class:

No Controlled Drug Status

Prescription type:

Never Valid To Prescribe As A VMP

Product summary:

BNF: 03040201

Summary of Product characteristics

OBJECT 1
B3 TREE POLLENS 2.5% W/V SOLUTION FOR SKIN PRICK
TEST
Summary of Product Characteristics Updated 10-Mar-2017 | Allergy
Therapeutics
1. Name of the medicinal product
B3 Tree Pollens 2.5% w/v
Solution for skin prick test
2. Qualitative and quantitative composition
B3 Tree Pollens 2.5% w/v* in 2 ml
*Nominal Value
B3 contains equal proportions of 10 purified allergen extracts of
pollen from the following Trees:
Alder
Ash
Beech
Birch (Silver)
Elm
Hazel
Oak
Plane
Poplar
Willow
_Alnus spp_
_Fraxinus spp_
_Fagus spp_
_Betula spp_
_Ulmus spp_
_Corylus spp _
_Quercus spp_
_Planatus spp_
_Populus spp _
_Salix_ spp
For the full list of excipients see Section 6.1.
3. Pharmaceutical form
Solution for skin prick test.
A clear solution.
4. Clinical particulars
4.1 Therapeutic indications
This medicinal product is indicated for the diagnosis of allergic (IgE
– mediated) diseases (type 1 in the
classification of Coombs and Gel).
4.2 Posology and method of administration
Taking a careful case history is a vital part of the investigation of
a patient with allergy symptoms since it
will usually identify those allergens most likely to be clinically
significant. Skin testing will help to
confirm the significance of the likely causative allergens, and
establish their relative importance.
Posology
_Paediatric population_
Prick testing in children is already possible after the first year of
life depending on the child's constitution,
but in general should not be performed before the age of 4.
Method of administration
The tests are usually carried out on the volar surface of the forearm:
In conditions of extreme outdoor
temperatures allow acclimatisation to room temperature: If test area
has been cleaned with water, alcohol
etc, wait at least two minutes to allow skin circulation to return to
normal.
Clean the skin with soap and water if necessary – but do not
sterilise with inorganic solvents or strong
antiseptics.
A ballpoint pen may be used to mark the skin (with suitable symbols)
adjacent to the planned test sites to
ident